Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas - PubMed (original) (raw)
Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas
S Laberge-le Couteulx et al. Nat Genet. 1999 Oct.
Abstract
Cavernous angiomas are vascular malformations mostly located in the central nervous system and characterized by enlarged capillary cavities without intervening brain parenchyma. Clinical symptoms include seizures, haemorrhage and focal neurological deficits. Cavernous angiomas prevalence is close to 0.5% in the general population. They may be inherited as an autosomal dominant condition in as much as 50% of cases. Cerebral cavernous malformations (CCM) loci were previously identified on 7q, 7p and 3q (refs 4,5). A strong founder effect was observed in the Hispano-American population, all families being linked to CCM1 on 7q (refs 4,7). CCM1 locus assignment was refined to a 4-cM interval bracketed by D7S2410 and D7S689 (ref. 8). Here we report a physical and transcriptional map of this interval and that CCM1, a gene whose protein product, KRIT1, interacts with RAP1A (also known as KREV1; ref. 9), a member of the RAS family of GTPases, is mutated in CCM1 families. Our data suggest the involvement of the RAP1A signal transduction pathway in vasculogenesis or angiogenesis.
Similar articles
- Spectrum and expression analysis of KRIT1 mutations in 121 consecutive and unrelated patients with Cerebral Cavernous Malformations.
Cavé-Riant F, Denier C, Labauge P, Cécillon M, Maciazek J, Joutel A, Laberge-Le Couteulx S, Tournier-Lasserve E. Cavé-Riant F, et al. Eur J Hum Genet. 2002 Nov;10(11):733-40. doi: 10.1038/sj.ejhg.5200870. Eur J Hum Genet. 2002. PMID: 12404106 - Clinical features of cerebral cavernous malformations patients with KRIT1 mutations.
Denier C, Labauge P, Brunereau L, Cavé-Riant F, Marchelli F, Arnoult M, Cecillon M, Maciazek J, Joutel A, Tournier-Lasserve E; Sociéte Française de Neurochirgurgie; Sociéte de Neurochirurgie de Langue Française. Denier C, et al. Ann Neurol. 2004 Feb;55(2):213-20. doi: 10.1002/ana.10804. Ann Neurol. 2004. PMID: 14755725 - A novel deletion mutation in CCM1 gene (krit1) is detected in a Chinese family with cerebral cavernous malformations.
Ji BH, Qin W, Sun T, Feng GY, He L, Wang YJ. Ji BH, et al. Yi Chuan Xue Bao. 2006 Feb;33(2):105-10. doi: 10.1016/S0379-4172(06)60028-0. Yi Chuan Xue Bao. 2006. PMID: 16529293 - [Cerebral cavernous malformation--its genetic and biological background].
Fujimura M, Tominaga T. Fujimura M, et al. Brain Nerve. 2008 Nov;60(11):1271-4. Brain Nerve. 2008. PMID: 19069160 Review. Japanese. - Recent insights into cerebral cavernous malformations: the molecular genetics of CCM.
Riant F, Bergametti F, Ayrignac X, Boulday G, Tournier-Lasserve E. Riant F, et al. FEBS J. 2010 Mar;277(5):1070-5. doi: 10.1111/j.1742-4658.2009.07535.x. Epub 2010 Jan 22. FEBS J. 2010. PMID: 20096038 Review.
Cited by
- Mitochondrial Ca(2+) and apoptosis.
Giorgi C, Baldassari F, Bononi A, Bonora M, De Marchi E, Marchi S, Missiroli S, Patergnani S, Rimessi A, Suski JM, Wieckowski MR, Pinton P. Giorgi C, et al. Cell Calcium. 2012 Jul;52(1):36-43. doi: 10.1016/j.ceca.2012.02.008. Epub 2012 Apr 3. Cell Calcium. 2012. PMID: 22480931 Free PMC article. Review. - Structural basis of the junctional anchorage of the cerebral cavernous malformations complex.
Gingras AR, Liu JJ, Ginsberg MH. Gingras AR, et al. J Cell Biol. 2012 Oct 1;199(1):39-48. doi: 10.1083/jcb.201205109. Epub 2012 Sep 24. J Cell Biol. 2012. PMID: 23007647 Free PMC article. - Vascular anomalies: from genetics toward models for therapeutic trials.
Uebelhoer M, Boon LM, Vikkula M. Uebelhoer M, et al. Cold Spring Harb Perspect Med. 2012 Aug 1;2(8):a009688. doi: 10.1101/cshperspect.a009688. Cold Spring Harb Perspect Med. 2012. PMID: 22908197 Free PMC article. Review. - Calm the raging hormone - A new therapeutic strategy involving progesterone-signaling for hemorrhagic CCMs.
Zhang J, Abou-Fadel JS. Zhang J, et al. Vessel Plus. 2021;5:48. Epub 2021 Jul 5. Vessel Plus. 2021. PMID: 35098046 Free PMC article. - Loss of p53 sensitizes mice with a mutation in Ccm1 (KRIT1) to development of cerebral vascular malformations.
Plummer NW, Gallione CJ, Srinivasan S, Zawistowski JS, Louis DN, Marchuk DA. Plummer NW, et al. Am J Pathol. 2004 Nov;165(5):1509-18. doi: 10.1016/S0002-9440(10)63409-8. Am J Pathol. 2004. PMID: 15509522 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical